WIN-2299 is an anticholinergic drug.[1] Human reactions to WIN-2299 include sedation (2 mg), LSD-like reactions (6 mg), and an acute delirious episode (10 mg).[2]
^Luduena, FP; Lands, AM (1954). "An investigation of the pharmacological actions of three potent antispasmodic compounds and their corresponding metho-salts". The Journal of Pharmacology and Experimental Therapeutics. 110 (3): 282–92. PMID13143475.
^Pennes, HH; Hoch, PH (1957). "Psychotomimetics, clinical and theoretical considerations: Harmine, Win-2299 and nalline". The American Journal of Psychiatry. 113 (10): 887–92. doi:10.1176/ajp.113.10.887. PMID13402982.